A systems approach defining constraints of the genome architecture on lineage selection and evolvability during somatic cancer evolution

作者: A. Rubben , O. Nordhoff

DOI: 10.1242/BIO.20122543

关键词:

摘要: Summary Most clinically distinguishable malignant tumors are characterized by specific mutations, patterns of chromosomal rearrangements and a predominant mechanism genetic instability but it remains unsolved whether modifications cancer genomes can be explained solely mutations selection through the microenvironment. It has been suggested that internal dynamics genomic as opposed to external evolutionary forces have significant complex impact on Darwinian species evolution. A similar situation expected for somatic evolution molecular key mechanisms encountered in also constitute prevalent mutation human cancers. This assumption is developed into systems approach carcinogenesis which focuses possible inner constraints genome architecture lineage during The proposed considered an analogy concept evolvability principal hypothesis permissive or restrictive effects exist measurable impact. postulates three classes evolution: i) mediated changes fitness cells lineage, ii) probabilities iii) gene designation physical functional redundancy. Physical redundancy copy number identical sequences. Functional regulatory element defined different elements, regardless number, coding same biological function within cell. Complex interactions may when multiple possibly manifest themselves at disparate times progression stages. Dissection putative mediating exerted provide algorithm understanding predicting well modifying individual patients.

参考文章(99)
Jen-Lan Tsao, Simon Tavaré, Reijo Salovaara, Jeremy R. Jass, Lauri A. Aaltonen, Darryl Shibata, Colorectal adenoma and cancer divergence. Evidence of multilineage progression. American Journal of Pathology. ,vol. 154, pp. 1815- 1824 ,(1999) , 10.1016/S0002-9440(10)65437-5
Jaap Verweij, Caroline Seynaeve, Stefan Sleijfer, GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial design. Advances in Experimental Medicine and Biology. ,vol. 610, pp. 144- 154 ,(2008) , 10.1007/978-0-387-73898-7_11
Peter Beighton, Greta Beighton, de la Chapelle, A. The Person Behind the Syndrome. pp. 209- 209 ,(1997) , 10.1007/978-1-4471-0925-9_118
L Foulds, The experimental study of tumor progression: a review. Cancer Research. ,vol. 14, pp. 327- 339 ,(1954)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Ian Tomlinson, Walter Bodmer, Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog Nature Medicine. ,vol. 5, pp. 11- 12 ,(1999) , 10.1038/4687
Lawrence A. Loeb, Mutator Phenotype May Be Required for Multistage Carcinogenesis Cancer Research. ,vol. 51, pp. 3075- 3079 ,(1991)
Elena Avdievich, Raju Kucherlapati, Mari Kuraguchi, Richard D. Kolodner, Edmund Wong, Winfried Edelmann, Kunhua Fan, Kan Yang, Anthony M. C. Brown, Martin Lipkin, The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis. Cancer Research. ,vol. 61, pp. 7934- 7942 ,(2001)